BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28785836)

  • 1. Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.
    Liang MI; Wong DH; Walsh CS; Farias-Eisner R; Cohen JG
    J Genet Couns; 2018 Feb; 27(1):177-186. PubMed ID: 28785836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
    Uyar D; Neary J; Monroe A; Nugent M; Simpson P; Geurts JL
    Gynecol Oncol; 2018 Jun; 149(3):565-569. PubMed ID: 29653687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression.
    Frey MK; Lee SS; Gerber D; Schwartz ZP; Martineau J; Lutz K; Reese E; Dalton E; Olsen A; Girdler J; Pothuri B; Boyd L; Curtin JP; Levine DA; Blank SV
    Gynecol Oncol; 2020 Apr; 157(1):280-286. PubMed ID: 32057464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "I think that a brief conversation from their provider can go a very long way": Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer.
    Mallen AR; Conley CC; Fuzzell L; Ketcher D; Augusto BM; McIntyre M; Barton LV; Townsend MK; Fridley BL; Tworoger SS; Wenham RM; Vadaparampil ST
    Support Care Cancer; 2021 May; 29(5):2663-2677. PubMed ID: 32975643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.
    Powell CB; Laurent C; Ciaravino G; Garcia C; Han L; Hoodfar E; Karlea A; Kobelka C; Lee J; Littell RD; Roh J; Vay A; Kushi LH
    Gynecol Oncol; 2020 Oct; 159(1):221-228. PubMed ID: 32778409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
    Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
    Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current Practice.
    Czekalski MA; Huziak RC; Durst AL; Taylor S; Mai PL
    JCO Precis Oncol; 2022 Jan; 6():e2100409. PubMed ID: 35025618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness of genetic counseling and genetic testing for hereditary gynecologic cancers among Korean healthcare providers: A survey.
    Kim M; Cheol Lim M; Ji Nam E; Huang D; Kim S; Jong Yoo H; Lee YY; Chang YJ;
    J Genet Couns; 2022 Apr; 31(2):546-553. PubMed ID: 34674340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
    Rana HQ; Kipnis L; Hehir K; Cronin A; Jaung T; Stokes SM; Fekrmandi F; Vatnick D; Matulonis UA; Garber JE; Wright AA
    Gynecol Oncol; 2021 Feb; 160(2):457-463. PubMed ID: 33229043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients.
    Gleeson M; Kentwell M; Meiser B; Do J; Nevin S; Taylor N; Barlow-Stewart K; Kirk J; James P; Scott CL; Williams R; Gamet K; Burke J; Murphy M; Antill YC; Pearn A; Pachter N; Ebzery C; Poplawski N; Friedlander M; Tucker KM;
    Gynecol Oncol; 2020 Aug; 158(2):431-439. PubMed ID: 32451123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
    Kentwell M; Dow E; Antill Y; Wrede CD; McNally O; Higgs E; Hamilton A; Ananda S; Lindeman GJ; Scott CL
    Gynecol Oncol; 2017 Apr; 145(1):130-136. PubMed ID: 28162234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic counseling referral for ovarian cancer patients: a call to action.
    Garcia C; Harrison K; Ring KL; Sullivan MW; Rauh LA; Modesitt SC
    Fam Cancer; 2019 Jul; 18(3):303-309. PubMed ID: 30993488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inadequate Rates of BRCA Testing with its Negative Consequences for Women with Epithelial Ovarian Cancer and their Families: an Overview of the Literature.
    Hoskins PJ
    Clin Oncol (R Coll Radiol); 2018 Aug; 30(8):472-483. PubMed ID: 29735311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?
    Audrain J; Rimer B; Cella D; Garber J; Peshkin BN; Ellis J; Schildkraut J; Stefanek M; Vogel V; Lerman C
    J Clin Oncol; 1998 Jan; 16(1):133-8. PubMed ID: 9440734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A survey of willingness about genetic counseling and tests in patients of epithelial ovarian cancer].
    Li L; Qiu L; Wu M
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(43):3412-3415. PubMed ID: 29179283
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
    Cohen PA; Nichols CB; Schofield L; Van Der Werf S; Pachter N
    Int J Gynecol Cancer; 2016 Jun; 26(5):892-7. PubMed ID: 27051053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome.
    Werner-Lin A; Ratner R; Hoskins LM; Lieber C
    J Genet Couns; 2015 Feb; 24(1):78-87. PubMed ID: 25011978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A patient-centered mobile health application to motivate use of genetic counseling among women with ovarian cancer: A pilot randomized controlled trial.
    Vogel RI; Niendorf K; Petzel S; Lee H; Teoh D; Blaes AH; Argenta P; Rivard C; Winterhoff B; Lee HY; Geller MA
    Gynecol Oncol; 2019 Apr; 153(1):100-107. PubMed ID: 30718125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer.
    Alimena S; Scarpetti L; Blouch EL; Rodgers L; Shannon K; Del Carmen M; Goodman A; Growdon WB; Eisenhauer E; Sisodia RC
    Int J Gynecol Cancer; 2020 Sep; 30(9):1397-1403. PubMed ID: 32447294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.